CEO David Endicott emphasized that "the second half of 2025 and especially the fourth quarter demonstrated the strength and momentum of our business." He highlighted recent innovation launches, citing ...

Stonesifer stated, "We expect top line growth of between 5% and 7%." He added, "We expect core diluted EPS to grow between 9% and 12%" for 2026. The outlook assumes aggregate eye care markets grow 3% ...